Pages that link to "Q88934500"

The following pages link to Valerie G Brunton (Q88934500):

Displaying 50 items.

• Actomyosin-mediated cellular tension drives increased tissue stiffness and β-catenin activation to induce epidermal hyperplasia and tumor growth (Q24613142) (← links)
• E-cadherin-integrin crosstalk in cancer invasion and metastasis (Q26851155) (← links)
• Stimulated Raman scattering microscopy: an emerging tool for drug discovery (Q28067096) (← links)
• Identification of Src-specific phosphorylation site on focal adhesion kinase: dissection of the role of Src SH2 and catalytic functions and their consequences for tumor cell behavior (Q28116742) (← links)
• The membrane targeting and spatial activation of Src, Yes and Fyn is influenced by palmitoylation and distinct RhoB/RhoD endosome requirements (Q28506568) (← links)
• The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs (Q29615910) (← links)
• An active Src kinase-beta-actin association is linked to actin dynamics at the periphery of colon cancer cells (Q30157917) (← links)
• Expression of kinase-defective mutants of c-Src in human metastatic colon cancer cells decreases Bcl-xL and increases oxaliplatin- and Fas-induced apoptosis (Q30163857) (← links)
• Src SH3/2 domain-mediated peripheral accumulation of Src and phospho-myosin is linked to deregulation of E-cadherin and the epithelial-mesenchymal transition (Q30164178) (← links)
• Rapid Discovery and Structure-Activity Relationships of Pyrazolopyrimidines That Potently Suppress Breast Cancer Cell Growth via SRC Kinase Inhibition with Exceptional Selectivity over ABL Kinase (Q30382639) (← links)
• Two-color photoactivatable probe for selective tracking of proteins and cells (Q30494159) (← links)
• Spatial regulation of RhoA activity during pancreatic cancer cell invasion driven by mutant p53 (Q30498093) (← links)
• Quantitative in vivo imaging of the effects of inhibiting integrin signaling via Src and FAK on cancer cell movement: effects on E-cadherin dynamics (Q30499765) (← links)
• Mutant p53 drives metastasis and overcomes growth arrest/senescence in pancreatic cancer (Q33591673) (← links)
• E7080, a multi-targeted tyrosine kinase inhibitor suppresses tumor cell migration and invasion (Q33968953) (← links)
• FAK deletion promotes p53-mediated induction of p21, DNA-damage responses and radio-resistance in advanced squamous cancer cells (Q34109901) (← links)
• Diversity of matriptase expression level and function in breast cancer. (Q34238503) (← links)
• Advances in Rho-dependent actin regulation and oncogenic transformation (Q34493115) (← links)
• Nuclear FAK controls chemokine transcription, Tregs, and evasion of anti-tumor immunity (Q34495723) (← links)
• Chemoresistant KM12C colon cancer cells are addicted to low cyclic AMP levels in a phosphodiesterase 4-regulated compartment via effects on phosphoinositide 3-kinase (Q34579970) (← links)
• HER2 overcomes PTEN (loss)-induced senescence to cause aggressive prostate cancer (Q35239611) (← links)
• Chronic myeloid leukemia stem cells are not dependent on Bcr-Abl kinase activity for their survival (Q35776432) (← links)
• The SRC-induced mesenchymal state in late-stage colon cancer cells (Q36155027) (← links)
• The role of focal-adhesion kinase in cancer - a new therapeutic opportunity (Q36216076) (← links)
• Use of a genetically engineered mouse model as a preclinical tool for HER2 breast cancer. (Q36627745) (← links)
• Identification of novel pathways linking epithelial-to-mesenchymal transition with resistance to HER2-targeted therapy (Q36998301) (← links)
• LKB1 haploinsufficiency cooperates with Kras to promote pancreatic cancer through suppression of p21-dependent growth arrest (Q37165210) (← links)
• Src and focal adhesion kinase as therapeutic targets in cancer (Q37215683) (← links)
• Is expression or activation of Src kinase associated with cancer-specific survival in ER-, PR- and HER2-negative breast cancer patients? (Q37362042) (← links)
• Quantitative real-time imaging of molecular dynamics during cancer cell invasion and metastasis in vivo (Q37582153) (← links)
• WT1 expression in breast cancer disrupts the epithelial/mesenchymal balance of tumour cells and correlates with the metabolic response to docetaxel (Q37721627) (← links)
• Src/FAK-mediated regulation of E-cadherin as a mechanism for controlling collective cell movement: insights from in vivo imaging (Q37916070) (← links)
• Src kinase inhibitors: promising cancer therapeutics? (Q37999452) (← links)
• Combining imaging and pathway profiling: an alternative approach to cancer drug discovery (Q38001717) (← links)
• Exploring mechanisms of acquired resistance to HER2 (human epidermal growth factor receptor 2)-targeted therapies in breast cancer (Q38238613) (← links)
• The role and therapeutic potential of the autotaxin-lysophosphatidate signalling axis in breast cancer (Q38246634) (← links)
• AXL Inhibitors in Cancer: A Medicinal Chemistry Perspective (Q38629669) (← links)
• Kindlin-1 regulates mitotic spindle formation by interacting with integrins and Plk-1. (Q39134536) (← links)
• Dasatinib inhibits mammary tumour development in a genetically engineered mouse model (Q39160945) (← links)
• QD-filled micelles which combine SPECT and optical imaging with light-induced activation of a platinum(IV) prodrug for anticancer applications (Q39172084) (← links)
• Selective tyrosine kinase inhibition of insulin-like growth factor-1 receptor inhibits human and mouse breast cancer-induced bone cell activity, bone remodeling, and osteolysis (Q39226296) (← links)
• The role of focal adhesion kinase catalytic activity on the proliferation and migration of squamous cell carcinoma cells (Q39493520) (← links)
• Use of photoactivation and photobleaching to monitor the dynamic regulation of E-cadherin at the plasma membrane (Q39685964) (← links)
• Dasatinib inhibits the development of metastases in a mouse model of pancreatic ductal adenocarcinoma (Q39725553) (← links)
• SRC family kinase activity is up-regulated in hormone-refractory prostate cancer. (Q39850321) (← links)
• Real-time study of E-cadherin and membrane dynamics in living animals: implications for disease modeling and drug development (Q39868686) (← links)
• Kindlin1 regulates microtubule function to ensure normal mitosis (Q39906864) (← links)
• A novel Src kinase inhibitor reduces tumour formation in a skin carcinogenesis model (Q39908229) (← links)
• Focal adhesion kinase is not required for Src-induced formation of invadopodia in KM12C colon cancer cells and can interfere with their assembly (Q39971306) (← links)
• Identification of potential biomarkers for measuring inhibition of Src kinase activity in colon cancer cells following treatment with dasatinib (Q40200272) (← links)